Rest EZ Inc. reported no revenue for the three and nine months ended December 31, 2025, maintaining a consistent trend from the previous fiscal period. The company incurred a net loss of $7,867 for the quarter and $7,900 for the nine-month period, slightly down from $7,900 in the same period last year. General and administrative expenses were recorded at $7,867 for the quarter, compared to $7,900 in the prior year, indicating a marginal reduction in operational costs. The company’s accumulated deficit stood at $286,101 as of December 31, 2025, unchanged from the previous reporting period.
In terms of operational developments, Rest EZ Inc. has been in full production and distribution of its sole product, the Rest EZ Sleep Aid Supplement, which is a liquid gel capsule. The company has not yet distributed this product to any customers, despite having sold 33,235 bottles for a total of $284,443 in previous sales. The company’s strategic focus remains on marketing this product to wholesalers and retailers, as well as through its online platform. The company has also undergone a leadership change, with Dylan Carson appointed as president on July 2, 2025, succeeding Brandon Sosa.
The company’s financial position remains precarious, with cash and cash equivalents totaling $300 as of December 31, 2025, consistent with the previous reporting period. The company has no current liabilities or accounts payable, indicating a lack of operational activity. The absence of revenue generation raises concerns about the company’s ability to sustain its operations without additional capital. The management has acknowledged that without further financing, the company may not be able to continue as a going concern.
Looking ahead, Rest EZ Inc. plans to enhance its sales strategy by expanding its reach to additional wholesalers and retail chain stores. The company aims to build its reputation and increase public sales over the next twelve months. However, the management has expressed substantial doubt regarding the company’s ability to continue operations without securing additional funding. The financial statements do not reflect any adjustments that might arise from the uncertainty surrounding the company’s future viability.
Overall, Rest EZ Inc. continues to face significant challenges in achieving profitability and maintaining operations. The company’s reliance on a single product and the lack of revenue generation highlight the need for strategic initiatives to improve its market position and financial health.
About REST EZ Inc.
Rest EZ, Inc. develops and markets sleep aid soft gel capsules containing natural ingredients like melatonin and amino acids. The company distributes its products through wholesalers, retail stores, and online channels, targeting adults with sleep difficulties. It relies on outsourced manufacturing, emphasizes product quality, and aims to build brand recognition through direct sales and marketing efforts in a competitive dietary supplement industry.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.